Mitochondrial enzyme FAHD1 reduces ROS in osteosarcoma

A model of how FAHD1 activity may modulate U2OS metabolism. (A) In U2OS cells, the tricarboxylic acid cycle operates independently, relying on both glycolysis and glutaminolysis to sustain the tricarboxylic acid flux. The PEP-PYR-OAA node remains stable, ensuring a consistent supply of mtGDP for the synthesis of succinate (SUC). (B) Overexpression of hFAHD1.1 in U2OS cells enhances glycolysis, leading to a reduction in oxaloacetate levels. This reduction impairs the citrate synthase (CS) reaction, consequently diminishing tricarboxylic acid flux and lowering complex I activity and ROS levels. To compensate for oxaloacetate depletion, the PEP-PYR-OAA node is upregulated, generating mtGDP and SUC. With decreased tricarboxylic acid cycle flux, NAD+ cannot be produced via complex I, prompting cytosolic lactate production to regenerate NAD+. This is facilitated by increased glycolysis. (C) Surprisingly, overexpression of hFAHD1.1-T192S in U2OS cells does not enhance glycolysis but shifts metabolism towards glutaminolysis. Similarly to hFAHD1.1 overexpression, oxaloacetate levels are reduced, impairing CS reaction and lowering tricarboxylic acid flux and complex I activity. As oxaloacetate levels may be drastically reduced, the PEP-PYR-OAA node may not sufficiently compensate. Consequently, the tricarboxylic acid cycle may be maintained through glutaminolysis. NADP+ may be generated via reductive isocitrate dehydrogenase 2 (IDH2) activity, or NAD+ via the nicotinamide (NAM) salvage pathway. Oxaloacetate may also be replenished through a non-canonical tricarboxylic acid cycle, involving citrate export into the cytosol (via SLC25A1), reduction, and subsequent import of malate and NAD+ into mitochondria. Malate can then be converted to oxaloacetate, providing fuel for complex I. (D) Overexpression of hFAHD1.1-K123A in U2OS cells appears to bypass glycolysis, downregulating PC, FAHD1, and PEPCK-M. This likely indicates a catalytic knockdown of FAHD1 via overexpression of a loss-of-function variant. Although the underlying mechanisms require further elucidation, it seems that glycolysis and the PEP-PYR-OAA node may be completely shut down, with cells relying solely on glutaminolysis. Despite similarities to the wild-type setup (A), this metabolic rerouting is weaker. Consequently, these cells exhibit increased mitochondrial content to compensate but otherwise behave similarly to wild-type cells in most experiments, including nearly unchanged ROS levels. Regulation of fumarate (FUM) levels may occur through adjacent pathways to compensate for the lack of biosynthesis.
Mitochondrial enzyme FAHD1 reduces ROS in osteosarcoma

Publication

Mitochondrial enzyme FAHD1 reduces ROS in osteosarcoma. (2024) Anne Heberle, et al. Sci Rep. 2024;14:9231. Figure: F8.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates PEP PEP ncbigene_synonym PAEP 5047
Homo sapiens Primates PEP PEP ncbigene_synonym PREP 5550
Homo sapiens Primates PEP PEP ncbigene_synonym PTPN22 26191
Homo sapiens Primates ADP ADP ncbigene_synonym WDTC1 23038
Homo sapiens Primates ATP ATP ncbigene_synonym ATP8A2 51761
Homo sapiens Primates LON LON ncbigene_synonym LONP1 9361
Homo sapiens Primates SLC25A51 SLC25A51 ncbigene_symbol SLC25A51 92014
Homo sapiens Primates HAD HAD ncbigene_synonym HADH 3033
Homo sapiens Primates [POH] POH ncbigene_synonym GNAS 2778
Homo sapiens Primates MAL MAL ncbigene_symbol MAL 4118
Homo sapiens Primates MAL MAL ncbigene_synonym MRTFA 57591
Homo sapiens Primates MAL MAL ncbigene_synonym TIRAP 114609
Homo sapiens Primates SLC25A1 SLC25A1 ncbigene_symbol SLC25A1 6576
Homo sapiens Primates [PC] PC ncbigene_symbol PC 5091
Homo sapiens Primates CIT CIT ncbigene_symbol CIT 11113
Homo sapiens Primates CIT CIT ncbigene_synonym DHDDS 79947
Homo sapiens Primates NADPH NADPH ncbigene_synonym DECR1 1666
Homo sapiens Primates Clas CLA ncbigene_synonym SELPLG 6404
Homo sapiens Primates Clas CIA ncbigene_synonym ASF1A 25842
Homo sapiens Primates Clas CIA ncbigene_synonym NCOA5 57727
Homo sapiens Primates dal DAI ncbigene_synonym ZBP1 81030
Homo sapiens Primates GLS GLS ncbigene_symbol GLS 2744
Homo sapiens Primates GLS GLS ncbigene_synonym GLS2 27165
Homo sapiens Primates HADH HADH ncbigene_synonym HADHA 3030
Homo sapiens Primates ACLY ACLY ncbigene_symbol ACLY 47
Homo sapiens Primates Ac ADCY famplex_relations ADCY1 107
Homo sapiens Primates Ac ADCY famplex_relations ADCY2 108
Homo sapiens Primates Ac ADCY famplex_relations ADCY3 109
Homo sapiens Primates Ac ADCY famplex_relations ADCY4 196883
Homo sapiens Primates Ac ADCY famplex_relations ADCY5 111
Homo sapiens Primates Ac ADCY famplex_relations ADCY6 112
Homo sapiens Primates Ac ADCY famplex_relations ADCY7 113
Homo sapiens Primates Ac ADCY famplex_relations ADCY8 114
Homo sapiens Primates Ac ADCY famplex_relations ADCY9 115
Homo sapiens Primates Ac ADCY famplex_relations ADCY10 55811
Homo sapiens Primates MAD MAD ncbigene_synonym AMPD1 270
Homo sapiens Primates MAD MAD ncbigene_synonym MXD1 4084
Homo sapiens Primates RAD RAD ncbigene_synonym RRAD 6236
Homo sapiens Primates НАДЕРЖ HP ncbigene_symbol HP 3240
Homo sapiens Primates НАДЕРЖ HEP ncbigene_synonym EPHB6 2051
Homo sapiens Primates НАДЕРЖ HEP ncbigene_synonym DNLZ 728489
Homo sapiens Primates GS] GS famplex_relations GNAL 2774
Homo sapiens Primates (LDH) LDH famplex_relations LDHA 3939
Homo sapiens Primates (LDH) LDH famplex_relations LDHB 3945
Homo sapiens Primates (LDH) LDH famplex_relations LDHC 3948
Homo sapiens Primates GEN GEN ncbigene_synonym GEN1 348654
Homo sapiens Primates TTP TTP ncbigene_synonym ZFP36 7538
Homo sapiens Primates TTP TTP ncbigene_synonym SH3BP4 23677

Chemical mentions

Word Match MeSH Name ChEBI
PEP PEP 2-(phosphonooxy)prop-2-enoic acid chebi:44897
ADP ADP L-alanyl-L-alpha-aspartyl-L-proline chebi:73342
ATP ATP ATP chebi:30616
Glucose Glucose aldehydo-D-glucose chebi:42758
ATP ATP ATP chebi:30616
NAD NAD adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} chebi:15846
Lactate lactate lactate chebi:24996
Glucose Glucose aldehydo-D-glucose chebi:42758
NAD NAD adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} chebi:15846
PEP PEP 2-(phosphonooxy)prop-2-enoic acid chebi:44897
Lactate lactate lactate chebi:24996
PEP PEP 2-(phosphonooxy)prop-2-enoic acid chebi:44897
NAD NAD adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} chebi:15846
PEP PEP 2-(phosphonooxy)prop-2-enoic acid chebi:44897
NAD NAD adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} chebi:15846
ATP ATP ATP chebi:30616
ATP ATP ATP chebi:30616
NADH NADH adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} chebi:57945
NAD NAD adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} chebi:15846
MAL mal malate chebi:15595
CIT Cit N(5)-carbamoyl-L-ornithine chebi:16349
MAL mal malate chebi:15595
NADPH NADPH 2'-O-phosphonatoadenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} chebi:57783
NAD NAD adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} chebi:15846
NADH NADH adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} chebi:57945
NADH NADH adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} chebi:57945
NAD NAD adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} chebi:15846
CIT Cit N(5)-carbamoyl-L-ornithine chebi:16349
MAL mal malate chebi:15595
NADH NADH adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} chebi:57945
Clas CLAs chebi:61159
dal DAL D-alanine chebi:15570
NAD NAD adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} chebi:15846
GLU Glu 2-aminopentanedioic acid chebi:18237
GLN Gln L-glutamine residue chebi:30011
NAD NAD adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} chebi:15846
NADH NADH adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} chebi:57945
NADH NADH adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} chebi:57945
NADH NADH adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} chebi:57945
OAA OAA chebi:132560
CIT Cit N(5)-carbamoyl-L-ornithine chebi:16349
NADH NADH adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} chebi:57945
ATP ATP ATP chebi:30616
PEP PEP 2-(phosphonooxy)prop-2-enoic acid chebi:44897
NADH NADH adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} chebi:57945
NAD NAD adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} chebi:15846
OAA OAA chebi:132560
CIT Cit N(5)-carbamoyl-L-ornithine chebi:16349
MAL mal malate chebi:15595
NAD NAD adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} chebi:15846
MAD MAD L-methionyl-L-alanyl-L-aspartic acid chebi:73609
GLU Glu 2-aminopentanedioic acid chebi:18237
NAD NAD adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} chebi:15846
NAD NAD adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} chebi:15846
NADH NADH adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} chebi:57945
ATP ATP ATP chebi:30616
ADP ADP L-alanyl-L-alpha-aspartyl-L-proline chebi:73342
NADH NADH adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} chebi:57945
ATP ATP ATP chebi:30616
NADA NADA N-[2-(3,4-dihydroxyphenyl)ethyl]acetamide chebi:125678
NAD NAD adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} chebi:15846
GLN Gln L-glutamine residue chebi:30011
MAL mal malate chebi:15595
DGL DGL (2R)-2-aminopentanedioic acid chebi:15966
NAD NAD adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} chebi:15846
GLU Glu 2-aminopentanedioic acid chebi:18237
GLN Gln L-glutamine residue chebi:30011
NADH NADH adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} chebi:57945
NADH NADH adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate} chebi:57945

Disease mentions

Word Match MeSH Name DOID